Anemocyte is a Biotech Manufacturing Organization (BMO); a biotech company active in the field of Cell and Gene Therapies (CGTs) that addresses CGT needs pro-actively offering one stop shop solutions and fostering exciting innovations.  

Our experience:

  • 14 years of GMP manufacturing of CGTs and biological drugs;
  • 61 years of Contract Manufacturing within our Group (Holding F.I.S.)

Our business:

  •  Process development and GMP capabilities (Somatic Cells, Non-Viral Modified Cells)
  •  High-Quality Plasmid for Viral Vector Manufacturing.
  •  Project 2020:  to address up to commercial scale needs for CGTs Including manufacturing of Viral Vectors.
  •  Big Data Analysis.